Ehlers-Danlos Syndrome in Orthopaedics: Etiology, Diagnosis, and Treatment Implications

Eric D. Shirley, Marlene DeMaio, Joann N Bodurtha

Research output: Contribution to journalArticle

Abstract

Ehlers-Danlos syndrome is a heterogeneous connective tissue condition characterized by varying degrees of skin hyperextensibility, joint hypermobility, and vascular fragility. Joint dislocations, musculoskeletal pain, atrophic scars, easy bleeding, vessel/viscera rupture, severe scoliosis, and obstetric complications may occur. These manifestations are secondary to abnormal collagen, with specific molecular defects in types I, III, and V collagen; they may also be related to tenascin-X, which has been identified in some patients. Ehlers-Danlos syndrome has been classified into 6 types, with variable degrees of joint instability, skin hyperextensibility, wound healing difficulty, and vascular fragility. Diagnosis begins with recognition of the signs and symptoms of global hypermobility and referring appropriate patients for genetic consultation. It is important to accurately identify patients with Ehlers-Danlos syndrome to initiate appropriate musculoskeletal treatment, optimize anesthetic and postoperative management, perform appropriate vascular screening, and help families address their concerns with other families and advocacy groups.

Original languageEnglish (US)
Pages (from-to)394-403
Number of pages10
JournalSports Health
Volume4
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Ehlers-Danlos Syndrome
Orthopedics
Blood Vessels
Joint Instability
Collagen Type V
Musculoskeletal Pain
Skin
Collagen Type III
Viscera
Scoliosis
Collagen Type I
Joint Dislocations
Connective Tissue
Wound Healing
Obstetrics
Signs and Symptoms
Cicatrix
Anesthetics
Rupture
Collagen

Keywords

  • Ehlers-Danlos
  • instability
  • ligament laxity

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Ehlers-Danlos Syndrome in Orthopaedics : Etiology, Diagnosis, and Treatment Implications. / Shirley, Eric D.; DeMaio, Marlene; Bodurtha, Joann N.

In: Sports Health, Vol. 4, No. 5, 09.2012, p. 394-403.

Research output: Contribution to journalArticle

@article{a27efe6f99174116aac789063ca18999,
title = "Ehlers-Danlos Syndrome in Orthopaedics: Etiology, Diagnosis, and Treatment Implications",
abstract = "Ehlers-Danlos syndrome is a heterogeneous connective tissue condition characterized by varying degrees of skin hyperextensibility, joint hypermobility, and vascular fragility. Joint dislocations, musculoskeletal pain, atrophic scars, easy bleeding, vessel/viscera rupture, severe scoliosis, and obstetric complications may occur. These manifestations are secondary to abnormal collagen, with specific molecular defects in types I, III, and V collagen; they may also be related to tenascin-X, which has been identified in some patients. Ehlers-Danlos syndrome has been classified into 6 types, with variable degrees of joint instability, skin hyperextensibility, wound healing difficulty, and vascular fragility. Diagnosis begins with recognition of the signs and symptoms of global hypermobility and referring appropriate patients for genetic consultation. It is important to accurately identify patients with Ehlers-Danlos syndrome to initiate appropriate musculoskeletal treatment, optimize anesthetic and postoperative management, perform appropriate vascular screening, and help families address their concerns with other families and advocacy groups.",
keywords = "Ehlers-Danlos, instability, ligament laxity",
author = "Shirley, {Eric D.} and Marlene DeMaio and Bodurtha, {Joann N}",
year = "2012",
month = "9",
doi = "10.1177/1941738112452385",
language = "English (US)",
volume = "4",
pages = "394--403",
journal = "Sports Health",
issn = "1941-7381",
publisher = "Sage Periodicals Press",
number = "5",

}

TY - JOUR

T1 - Ehlers-Danlos Syndrome in Orthopaedics

T2 - Etiology, Diagnosis, and Treatment Implications

AU - Shirley, Eric D.

AU - DeMaio, Marlene

AU - Bodurtha, Joann N

PY - 2012/9

Y1 - 2012/9

N2 - Ehlers-Danlos syndrome is a heterogeneous connective tissue condition characterized by varying degrees of skin hyperextensibility, joint hypermobility, and vascular fragility. Joint dislocations, musculoskeletal pain, atrophic scars, easy bleeding, vessel/viscera rupture, severe scoliosis, and obstetric complications may occur. These manifestations are secondary to abnormal collagen, with specific molecular defects in types I, III, and V collagen; they may also be related to tenascin-X, which has been identified in some patients. Ehlers-Danlos syndrome has been classified into 6 types, with variable degrees of joint instability, skin hyperextensibility, wound healing difficulty, and vascular fragility. Diagnosis begins with recognition of the signs and symptoms of global hypermobility and referring appropriate patients for genetic consultation. It is important to accurately identify patients with Ehlers-Danlos syndrome to initiate appropriate musculoskeletal treatment, optimize anesthetic and postoperative management, perform appropriate vascular screening, and help families address their concerns with other families and advocacy groups.

AB - Ehlers-Danlos syndrome is a heterogeneous connective tissue condition characterized by varying degrees of skin hyperextensibility, joint hypermobility, and vascular fragility. Joint dislocations, musculoskeletal pain, atrophic scars, easy bleeding, vessel/viscera rupture, severe scoliosis, and obstetric complications may occur. These manifestations are secondary to abnormal collagen, with specific molecular defects in types I, III, and V collagen; they may also be related to tenascin-X, which has been identified in some patients. Ehlers-Danlos syndrome has been classified into 6 types, with variable degrees of joint instability, skin hyperextensibility, wound healing difficulty, and vascular fragility. Diagnosis begins with recognition of the signs and symptoms of global hypermobility and referring appropriate patients for genetic consultation. It is important to accurately identify patients with Ehlers-Danlos syndrome to initiate appropriate musculoskeletal treatment, optimize anesthetic and postoperative management, perform appropriate vascular screening, and help families address their concerns with other families and advocacy groups.

KW - Ehlers-Danlos

KW - instability

KW - ligament laxity

UR - http://www.scopus.com/inward/record.url?scp=84865294668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865294668&partnerID=8YFLogxK

U2 - 10.1177/1941738112452385

DO - 10.1177/1941738112452385

M3 - Article

C2 - 23016112

AN - SCOPUS:84865294668

VL - 4

SP - 394

EP - 403

JO - Sports Health

JF - Sports Health

SN - 1941-7381

IS - 5

ER -